Literature DB >> 25005462

Bone marrow derived stem cells in joint and bone diseases: a concise review.

Antonio Marmotti1, Laura de Girolamo, Davide Edoardo Bonasia, Matteo Bruzzone, Silvia Mattia, Roberto Rossi, Angela Montaruli, Federico Dettoni, Filippo Castoldi, Giuseppe Peretti.   

Abstract

Stem cells have huge applications in the field of tissue engineering and regenerative medicine. Their use is currently not restricted to the life-threatening diseases but also extended to disorders involving the structural tissues, which may not jeopardize the patients' life, but certainly influence their quality of life. In fact, a particularly popular line of research is represented by the regeneration of bone and cartilage tissues to treat various orthopaedic disorders. Most of these pioneering research lines that aim to create new treatments for diseases that currently have limited therapies are still in the bench of the researchers. However, in recent years, several clinical trials have been started with satisfactory and encouraging results. This article aims to review the concept of stem cells and their characterization in terms of site of residence, differentiation potential and therapeutic prospective. In fact, while only the bone marrow was initially considered as a "reservoir" of this cell population, later, adipose tissue and muscle tissue have provided a considerable amount of cells available for multiple differentiation. In reality, recently, the so-called "stem cell niche" was identified as the perivascular space, recognizing these cells as almost ubiquitous. In the field of bone and joint diseases, their potential to differentiate into multiple cell lines makes their application ideally immediate through three main modalities: (1) cells selected by withdrawal from bone marrow, subsequent culture in the laboratory, and ultimately transplant at the site of injury; (2) bone marrow aspirate, concentrated and directly implanted into the injury site; (3) systemic mobilization of stem cells and other bone marrow precursors by the use of growth factors. The use of this cell population in joint and bone disease will be addressed and discussed, analysing both the clinical outcomes but also the basic research background, which has justified their use for the treatment of bone, cartilage and meniscus tissues.

Entities:  

Mesh:

Year:  2014        PMID: 25005462     DOI: 10.1007/s00264-014-2445-4

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  190 in total

1.  Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis.

Authors:  Mohsen Emadedin; Naser Aghdami; Leila Taghiyar; Roghayeh Fazeli; Reza Moghadasali; Shahrbanoo Jahangir; Reza Farjad; Mohamadreza Baghaban Eslaminejad
Journal:  Arch Iran Med       Date:  2012-07       Impact factor: 1.354

2.  Shrinkage-free preparation of scaffold-free cartilage-like disk-shaped cell sheet using human bone marrow mesenchymal stem cells.

Authors:  Satoshi Maeda; Takashi Fujitomo; Takahiro Okabe; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  J Biosci Bioeng       Date:  2010-12-24       Impact factor: 2.894

3.  Fabrication and cell affinity of biomimetic structured PLGA/articular cartilage ECM composite scaffold.

Authors:  Xifu Zheng; Fei Yang; Shenguo Wang; Shibi Lu; Weiguo Zhang; Shuyun Liu; Jingxiang Huang; Aiyuan Wang; Baosheng Yin; Ning Ma; Li Zhang; Wenjing Xu; Quanyi Guo
Journal:  J Mater Sci Mater Med       Date:  2011-02-03       Impact factor: 3.896

Review 4.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

5.  Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integration.

Authors:  Barbara Dozza; Claudia Di Bella; Enrico Lucarelli; Gianluca Giavaresi; Milena Fini; Pier Luigi Tazzari; Sandro Giannini; Davide Donati
Journal:  J Orthop Res       Date:  2011-01-31       Impact factor: 3.494

6.  Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites.

Authors:  Hansoo Park; Johnna S Temenoff; Yasuhiko Tabata; Arnold I Caplan; Robert M Raphael; John A Jansen; Antonios G Mikos
Journal:  J Biomed Mater Res A       Date:  2009-03-15       Impact factor: 4.396

7.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

8.  Injectable mesenchymal stem cell therapy for large cartilage defects--a porcine model.

Authors:  Kevin B L Lee; James H P Hui; Im Chim Song; Lenny Ardany; Eng Hin Lee
Journal:  Stem Cells       Date:  2007-07-26       Impact factor: 6.277

9.  Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study.

Authors:  Wan-Ju Li; Hongsen Chiang; Tzong-Fu Kuo; Hsuan-Shu Lee; Ching-Chuan Jiang; Rocky S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2009-01       Impact factor: 3.963

10.  Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study.

Authors:  A Marmotti; S Mattia; M Bruzzone; S Buttiglieri; A Risso; D E Bonasia; D Blonna; F Castoldi; R Rossi; C Zanini; E Ercole; E Defabiani; C Tarella; G M Peretti
Journal:  Stem Cells Int       Date:  2012-03-07       Impact factor: 5.443

View more
  18 in total

1.  Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation.

Authors:  Roberto Buda; Francesca Vannini; Francesco Castagnini; Marco Cavallo; Alberto Ruffilli; Laura Ramponi; Gherardo Pagliazzi; Sandro Giannini
Journal:  Int Orthop       Date:  2015-02-08       Impact factor: 3.075

2.  Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro.

Authors:  Etsuko Okumachi; Sang Yang Lee; Takahiro Niikura; Takashi Iwakura; Yoshihiro Dogaki; Takahiro Waki; Shunsuke Takahara; Takeshi Ueha; Yoshitada Sakai; Ryosuke Kuroda; Masahiro Kurosaka
Journal:  Int Orthop       Date:  2014-10-23       Impact factor: 3.075

3.  Fully automated, clinical-grade bone marrow processing: a single-centre experience.

Authors:  Benedetta Mazzanti; Serena Urbani; Simone Dal Pozzo; Paola Bufano; Lara Ballerini; Alessia Gelli; Irene Sodi; Irene Donnini; Massimo Di Gioia; Stefano Guidi; Julien Camisani; Riccardo Saccardi
Journal:  Blood Transfus       Date:  2016-09-27       Impact factor: 3.443

4.  Tissue engineering and regenerative orthopaedics (TERO).

Authors:  Marko Pećina; Slobodan Vukičević
Journal:  Int Orthop       Date:  2014-08-12       Impact factor: 3.075

Review 5.  Regenerative approaches for the treatment of early OA.

Authors:  L de Girolamo; E Kon; G Filardo; A G Marmotti; F Soler; G M Peretti; F Vannini; H Madry; S Chubinskaya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

6.  Clinical and radiographic outcomes of concentrated bone marrow aspirate with allograft and demineralized bone matrix for posterolateral and interbody lumbar fusion in elderly patients.

Authors:  Remi M Ajiboye; Jason T Hamamoto; Mark A Eckardt; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2015-07-14       Impact factor: 3.134

Review 7.  The Current Perspectives of Stem Cell Therapy in Orthopedic Surgery.

Authors:  Serkan Akpancar; Oner Tatar; Hasan Turgut; Faruk Akyildiz; Safak Ekinci
Journal:  Arch Trauma Res       Date:  2016-08-16

Review 8.  Injections in the osteoarthritic knee: a review of current treatment options.

Authors:  Gerardo Fusco; Francesco M Gambaro; Berardo Di Matteo; Elizaveta Kon
Journal:  EFORT Open Rev       Date:  2021-06-28

9.  Stem cell origin differently affects bone tissue engineering strategies.

Authors:  Monica Mattioli-Belmonte; Gabriella Teti; Viviana Salvatore; Stefano Focaroli; Monia Orciani; Manuela Dicarlo; Milena Fini; Giovanna Orsini; Roberto Di Primio; Mirella Falconi
Journal:  Front Physiol       Date:  2015-09-24       Impact factor: 4.566

10.  Are biological agents toxic to human chondrocytes and osteocytes?

Authors:  Mehmet Isyar; Bulent Bilir; Ibrahim Yilmaz; Selami Cakmak; Duygu Yasar Sirin; Aliye Yildirim Guzelant; Mahir Mahirogullari
Journal:  J Orthop Surg Res       Date:  2015-07-30       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.